593 related articles for article (PubMed ID: 19684145)
1. Sensorineural hearing loss in patients with mixed connective tissue disease: immunological markers and cytokine levels.
Hajas A; Szodoray P; Barath S; Sipka S; Rezes S; Zeher M; Sziklai I; Szegedi G; Bodolay E
J Rheumatol; 2009 Sep; 36(9):1930-6. PubMed ID: 19684145
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease.
Komatireddy GR; Wang GS; Sharp GC; Hoffman RW
J Rheumatol; 1997 Feb; 24(2):319-22. PubMed ID: 9034990
[TBL] [Abstract][Full Text] [Related]
3. Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease.
Bakri Hassan A; Rönnelid J; Gunnarsson I; Karlsson G; Berg L; Lundberg I
J Autoimmun; 1998 Oct; 11(5):503-8. PubMed ID: 9802936
[TBL] [Abstract][Full Text] [Related]
4. The frequency of anti-beta2-glycoprotein I antibodies is low and these antibodies are associated with pulmonary hypertension in mixed connective tissue disease.
Hasegawa EM; Caleiro MT; Fuller R; Carvalho JF
Lupus; 2009 Jun; 18(7):618-21. PubMed ID: 19433462
[TBL] [Abstract][Full Text] [Related]
5. Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension.
Vegh J; Szodoray P; Kappelmayer J; Csipo I; Udvardy M; Lakos G; Aleksza M; Soltesz P; Szilágyi A; Zeher M; Szegedi G; Bodolay E
Scand J Immunol; 2006 Jul; 64(1):69-76. PubMed ID: 16784493
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells in peripheral blood of patients with mixed connective tissue disease.
Baráth S; Sipka S; Aleksza M; Szegedi A; Szodoray P; Végh J; Szegedi G; Bodolay E
Scand J Rheumatol; 2006; 35(4):300-4. PubMed ID: 16882595
[TBL] [Abstract][Full Text] [Related]
7. Assessment of serum antibodies in patients with rapidly progressive sensorineural hearing loss and Menière's disease.
Gottschlich S; Billings PB; Keithley EM; Weisman MH; Harris JP
Laryngoscope; 1995 Dec; 105(12 Pt 1):1347-52. PubMed ID: 8523990
[TBL] [Abstract][Full Text] [Related]
8. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
[TBL] [Abstract][Full Text] [Related]
9. Raynaud's phenomenon in mixed connective tissue disease.
Grader-Beck T; Wigley FM
Rheum Dis Clin North Am; 2005 Aug; 31(3):465-81, vi. PubMed ID: 16084319
[TBL] [Abstract][Full Text] [Related]
10. Immunological analysis of pulmonary hypertension in connective tissue diseases.
Nishimaki T; Aotsuka S; Kondo H; Yamamoto K; Takasaki Y; Sumiya M; Yokohari R
J Rheumatol; 1999 Nov; 26(11):2357-62. PubMed ID: 10555891
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus.
Margaux J; Hayem G; Palazzo E; Chazerain P; De Bandt M; Haim T; Kahn MF; Meyer O
Rev Rhum Engl Ed; 1998 Jun; 65(6):378-86. PubMed ID: 9670329
[TBL] [Abstract][Full Text] [Related]
12. Sensorineural hearing loss in adults with sickle cell anaemia.
Onakoya PA; Nwaorgu OG; Shokunbi WA
Afr J Med Med Sci; 2002 Mar; 31(1):21-4. PubMed ID: 12518924
[TBL] [Abstract][Full Text] [Related]
13. [A possible role of anti-endothelial cell antibody in the sera of MCTD patients on pulmonary vascular damage relating to pulmonary hypertension].
Sasaki N; Kurose A; Inoue H; Sawai T
Ryumachi; 2002 Dec; 42(6):885-94. PubMed ID: 12632608
[TBL] [Abstract][Full Text] [Related]
14. Anti-endothelial cell antibodies in the sera of patients with mixed connective tissue disease--the clinical significance.
Watanabe H; Kaise S; Takeda I; Matsuzaki H; Kobayashi H; Nishimaki T; Kasukawa R
Fukushima J Med Sci; 1997 Jun; 43(1):13-28. PubMed ID: 9431781
[TBL] [Abstract][Full Text] [Related]
15. Anti-68 kDa antibodies in autoimmune sensorineural hearing loss: are these autoantibodies really a diagnostic tool?
Bonaguri C; Orsoni JG; Zavota L; Monica C; Russo A; Pellistri I; Rubino P; Giovannelli L; Manzotti F; Piazza F
Autoimmunity; 2007 Feb; 40(1):73-8. PubMed ID: 17364500
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic utility of measuring tumor necrosis factor in the peripheral circulation of patients with immune-mediated sensorineural hearing loss.
Svrakic M; Pathak S; Goldofsky E; Hoffman R; Chandrasekhar SS; Sperling N; Alexiades G; Ashbach M; Vambutas A
Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1052-8. PubMed ID: 23165380
[TBL] [Abstract][Full Text] [Related]
17. Hearing loss in progressive systemic sclerosis patients: a comparative study.
Kastanioudakis I; Ziavra N; Politi EN; Exarchakos G; Drosos AA; Skevas A
Otolaryngol Head Neck Surg; 2001 May; 124(5):522-5. PubMed ID: 11337656
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D insufficiency in a large MCTD population.
Hajas A; Sandor J; Csathy L; Csipo I; Barath S; Paragh G; Seres I; Szegedi G; Shoenfeld Y; Bodolay E
Autoimmun Rev; 2011 Apr; 10(6):317-24. PubMed ID: 21156217
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of antibodies to TS1-RNA in patients with mixed connective tissue disease.
Ikeda K; Takasaki Y; Hirokawa K; Takeuchi K; Hashimoto H
J Rheumatol; 2003 May; 30(5):998-1005. PubMed ID: 12734895
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of paraoxonase activity in patients with mixed connective tissue disease.
Bodolay E; Seres I; Szodoray P; Csípo I; Jakab Z; Vegh J; Szilagyi A; Szegedi G; Paragh G
J Rheumatol; 2008 Feb; 35(2):237-43. PubMed ID: 18085736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
